Acyclovir and Anti-hbc igg antibody positive - a phase IV clinical study of FDA data

Summary:

Anti-hbc igg antibody positive is reported only by a few people who take Acyclovir.

The phase IV clinical study analyzes which people take Acyclovir and have Anti-hbc igg antibody positive. It is created by eHealthMe based on reports of 33,006 people who have side effects while taking Acyclovir from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

33,006 people reported to have side effects when taking Acyclovir.
Among them, 2 people (0.01%) have Anti-hbc igg antibody positive.


What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 34,450 Acyclovir users for its effectiveness, alternative drugs and more.

What is Anti-hbc igg antibody positive?

Anti-hbc igg antibody positive is found to be associated with 96 drugs and 27 conditions by eHealthMe.

Number of Acyclovir and Anti-hbc igg antibody positive reports submitted per year:

Could Acyclovir cause Anti-hbc igg antibody positive?

Gender of people who have Anti-hbc igg antibody positive when taking Acyclovir *:

  • female: 50 %
  • male: 50 %

Age of people who have Anti-hbc igg antibody positive when taking Acyclovir *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 0.0 %

Common drugs people take besides Acyclovir *:

  1. Zidovudine: 1 person, 50.00%
  2. Warfarin Sodium: 1 person, 50.00%
  3. Gabapentin: 1 person, 50.00%
  4. Cotrim: 1 person, 50.00%
  5. Bupropion Hydrochloride: 1 person, 50.00%
  6. Atovaquone: 1 person, 50.00%

Common side effects people have besides Anti-hbc igg antibody positive *:

  1. Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 50.00%
  2. Hepatitis B Surface Antigen Positive: 1 person, 50.00%
  3. Hepatic Steatosis (fatty liver disease): 1 person, 50.00%
  4. Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 1 person, 50.00%
  5. Haemochromatosis (body to absorb more iron than usual from food): 1 person, 50.00%
  6. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 50.00%
  7. Fatigue (feeling of tiredness): 1 person, 50.00%

Common conditions people have *:

  1. Hiv Infection: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and have Anti-hbc igg antibody positive?

Check whether Anti-hbc igg antibody positive is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Anti-hbc igg antibody positive and when was it recovered:

Expand to all the drugs that have ingredients of acyclovir:

Alternative drugs to, pros and cons of Acyclovir:

Common Acyclovir side effects:

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Anti-hbc igg antibody positive treatments and more:

COVID vaccines that are related to Anti-hbc igg antibody positive:

All the drugs that are associated with Anti-hbc igg antibody positive:

All the conditions that are associated with Anti-hbc igg antibody positive:

How the study uses the data?

The study uses data from the FDA. It is based on acyclovir (the active ingredients of Acyclovir) and Acyclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: